Global Biologic Therapeutics Drugs Market Research Report 2023(Status and Outlook)

Global Biologic Therapeutics Drugs Market Research Report 2023(Status and Outlook)



Report Overview

Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural sources such as animals, humans, and microorganisms that are further utilized to make therapeutic products such as vaccines, blood components, and recombinant therapeutic proteins.

The Global Biologic Therapeutics Drugs Market Size was estimated at USD 322420.00 million in 2022 and is projected to reach USD 484800.47 million by 2029, exhibiting a CAGR of 6.00% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Biologic Therapeutics Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biologic Therapeutics Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biologic Therapeutics Drugs market in any manner.

Global Biologic Therapeutics Drugs Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Pfizer

AstraZeneca

Novartis

Merck

Smith Medical

GlaxoSmithKline

Concord Biotech

Aurobindo Pharma

H. Lundbeck

Retractable Technologies

Market Segmentation (by Type)

Avian Cell Culture

Yeast

Bacteria

Insects Cell Culture

Transgenics

Market Segmentation (by Application)

Hospital

Homecare

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Biologic Therapeutics Drugs Market

Overview of the regional outlook of the Biologic Therapeutics Drugs Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Biologic Therapeutics Drugs
1.2 Key Market Segments
1.2.1 Biologic Therapeutics Drugs Segment by Type
1.2.2 Biologic Therapeutics Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Biologic Therapeutics Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Biologic Therapeutics Drugs Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Biologic Therapeutics Drugs Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Biologic Therapeutics Drugs Market Competitive Landscape
3.1 Global Biologic Therapeutics Drugs Sales by Manufacturers (2018-2023)
3.2 Global Biologic Therapeutics Drugs Revenue Market Share by Manufacturers (2018-2023)
3.3 Biologic Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Biologic Therapeutics Drugs Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Biologic Therapeutics Drugs Sales Sites, Area Served, Product Type
3.6 Biologic Therapeutics Drugs Market Competitive Situation and Trends
3.6.1 Biologic Therapeutics Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biologic Therapeutics Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Biologic Therapeutics Drugs Industry Chain Analysis
4.1 Biologic Therapeutics Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Biologic Therapeutics Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Biologic Therapeutics Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biologic Therapeutics Drugs Sales Market Share by Type (2018-2023)
6.3 Global Biologic Therapeutics Drugs Market Size Market Share by Type (2018-2023)
6.4 Global Biologic Therapeutics Drugs Price by Type (2018-2023)
7 Biologic Therapeutics Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biologic Therapeutics Drugs Market Sales by Application (2018-2023)
7.3 Global Biologic Therapeutics Drugs Market Size (M USD) by Application (2018-2023)
7.4 Global Biologic Therapeutics Drugs Sales Growth Rate by Application (2018-2023)
8 Biologic Therapeutics Drugs Market Segmentation by Region
8.1 Global Biologic Therapeutics Drugs Sales by Region
8.1.1 Global Biologic Therapeutics Drugs Sales by Region
8.1.2 Global Biologic Therapeutics Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Biologic Therapeutics Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biologic Therapeutics Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biologic Therapeutics Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biologic Therapeutics Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biologic Therapeutics Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Pfizer
9.1.1 Pfizer Biologic Therapeutics Drugs Basic Information
9.1.2 Pfizer Biologic Therapeutics Drugs Product Overview
9.1.3 Pfizer Biologic Therapeutics Drugs Product Market Performance
9.1.4 Pfizer Business Overview
9.1.5 Pfizer Biologic Therapeutics Drugs SWOT Analysis
9.1.6 Pfizer Recent Developments
9.2 AstraZeneca
9.2.1 AstraZeneca Biologic Therapeutics Drugs Basic Information
9.2.2 AstraZeneca Biologic Therapeutics Drugs Product Overview
9.2.3 AstraZeneca Biologic Therapeutics Drugs Product Market Performance
9.2.4 AstraZeneca Business Overview
9.2.5 AstraZeneca Biologic Therapeutics Drugs SWOT Analysis
9.2.6 AstraZeneca Recent Developments
9.3 Novartis
9.3.1 Novartis Biologic Therapeutics Drugs Basic Information
9.3.2 Novartis Biologic Therapeutics Drugs Product Overview
9.3.3 Novartis Biologic Therapeutics Drugs Product Market Performance
9.3.4 Novartis Business Overview
9.3.5 Novartis Biologic Therapeutics Drugs SWOT Analysis
9.3.6 Novartis Recent Developments
9.4 Merck
9.4.1 Merck Biologic Therapeutics Drugs Basic Information
9.4.2 Merck Biologic Therapeutics Drugs Product Overview
9.4.3 Merck Biologic Therapeutics Drugs Product Market Performance
9.4.4 Merck Business Overview
9.4.5 Merck Biologic Therapeutics Drugs SWOT Analysis
9.4.6 Merck Recent Developments
9.5 Smith Medical
9.5.1 Smith Medical Biologic Therapeutics Drugs Basic Information
9.5.2 Smith Medical Biologic Therapeutics Drugs Product Overview
9.5.3 Smith Medical Biologic Therapeutics Drugs Product Market Performance
9.5.4 Smith Medical Business Overview
9.5.5 Smith Medical Biologic Therapeutics Drugs SWOT Analysis
9.5.6 Smith Medical Recent Developments
9.6 GlaxoSmithKline
9.6.1 GlaxoSmithKline Biologic Therapeutics Drugs Basic Information
9.6.2 GlaxoSmithKline Biologic Therapeutics Drugs Product Overview
9.6.3 GlaxoSmithKline Biologic Therapeutics Drugs Product Market Performance
9.6.4 GlaxoSmithKline Business Overview
9.6.5 GlaxoSmithKline Recent Developments
9.7 Concord Biotech
9.7.1 Concord Biotech Biologic Therapeutics Drugs Basic Information
9.7.2 Concord Biotech Biologic Therapeutics Drugs Product Overview
9.7.3 Concord Biotech Biologic Therapeutics Drugs Product Market Performance
9.7.4 Concord Biotech Business Overview
9.7.5 Concord Biotech Recent Developments
9.8 Aurobindo Pharma
9.8.1 Aurobindo Pharma Biologic Therapeutics Drugs Basic Information
9.8.2 Aurobindo Pharma Biologic Therapeutics Drugs Product Overview
9.8.3 Aurobindo Pharma Biologic Therapeutics Drugs Product Market Performance
9.8.4 Aurobindo Pharma Business Overview
9.8.5 Aurobindo Pharma Recent Developments
9.9 H. Lundbeck
9.9.1 H. Lundbeck Biologic Therapeutics Drugs Basic Information
9.9.2 H. Lundbeck Biologic Therapeutics Drugs Product Overview
9.9.3 H. Lundbeck Biologic Therapeutics Drugs Product Market Performance
9.9.4 H. Lundbeck Business Overview
9.9.5 H. Lundbeck Recent Developments
9.10 Retractable Technologies
9.10.1 Retractable Technologies Biologic Therapeutics Drugs Basic Information
9.10.2 Retractable Technologies Biologic Therapeutics Drugs Product Overview
9.10.3 Retractable Technologies Biologic Therapeutics Drugs Product Market Performance
9.10.4 Retractable Technologies Business Overview
9.10.5 Retractable Technologies Recent Developments
10 Biologic Therapeutics Drugs Market Forecast by Region
10.1 Global Biologic Therapeutics Drugs Market Size Forecast
10.2 Global Biologic Therapeutics Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Biologic Therapeutics Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Biologic Therapeutics Drugs Market Size Forecast by Region
10.2.4 South America Biologic Therapeutics Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Biologic Therapeutics Drugs by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Biologic Therapeutics Drugs Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Biologic Therapeutics Drugs by Type (2024-2029)
11.1.2 Global Biologic Therapeutics Drugs Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Biologic Therapeutics Drugs by Type (2024-2029)
11.2 Global Biologic Therapeutics Drugs Market Forecast by Application (2024-2029)
11.2.1 Global Biologic Therapeutics Drugs Sales (K MT) Forecast by Application
11.2.2 Global Biologic Therapeutics Drugs Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings